Drugs, Nonprescription -- Labeling -- United StatesSee also what's at your library, or elsewhere.
Broader terms: |
Filed under: Drugs, Nonprescription -- Labeling -- United States- Advertising for over-the-counter antacids : final staff report and recommendations. (Federal Trade Commission, Bureau of Consumer Protection, 1983), by United States. Federal Trade Commission. Bureau of Consumer Protection (page images at HathiTrust)
- Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992. (U.S. G.P.O. :, 1992), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation and United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
Items below (if any) are from related and broader terms.
Filed under: Drugs -- Labeling -- United States- Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- Project Label : alphabetical listings by drug product. (Washington : U. S. Dept. of Justice, Drug Enforcement Administration, 1978), by United States. Drug Enforcement Administration (page images at HathiTrust)
- Project Label : alphabetical listings by drug product. (U.S. Dept. of Justice, Drug Enforcement Administration, 1976), by United States. Drug Enforcement Administration (page images at HathiTrust)
- Project Label : alphabetical listing by drug distributors. (U.S. Dept. of Justice, Drug Enforcement Administration, Office of Science and Technology, Special Programs Division, Drug Information Section, 1976), by United States. Drug Enforcement Administration (page images at HathiTrust)
- Project label : alphabetical listings by controlled generic drug ingredients. (Dept. of Justice, Drug Enforcement Administration, Office of Compliance and Regulatory Affairs, Regulatory Support Division, Information Systems Section : for sale by the Supt. of Docs., U.S. Govt. Print. Off., 1979), by United States. Drug Enforcement Administration (page images at HathiTrust)
- Drug labeling in developing countries. (U.S. Congress, Office of Technology Assessment, 1993), by United States Congress Office of Technology Assessment (page images at HathiTrust)
- "Man-in-the-plant", FDA's failure to regulate deceptive drug labeling hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978. (U.S. Govt. Print. Off., 1978), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
- "Man-in-the-plant" revisited, a deceptive drug labeling practice continues hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Committee, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980. (U.S. Govt. Print. Off., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
- Implications of drug labeling and off-label use (The Office ;, 1996), by Sarah F. Jagger, United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations, and United States General Accounting Office (page images at HathiTrust)
- Project label : alphabetical listings by drug labeler. (U. S. Dept. of Justice, Drug Enforcement Administration :, 1979), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs. Information Systems Section (page images at HathiTrust)
- Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992. (U.S. G.P.O. :, 1992), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation and United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
- Off label drug use and FDA review of supplemental drug applications (U.S. G.P.O. :, 1997), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations (page images at HathiTrust)
- Foods, Drugs, and Cosmetics : hearings before the United States Senate Committee on Commerce, Subcommittee on S. 5, Seventy- Fourth Congress, first session, on Mar. 2, 8, 9, 1935. (U.S. G.P.O., 1935), by United States Senate Committee on Commerce (page images at HathiTrust)
- Read the label on foods, drugs, devices, cosmetics, and household chemicals. (U.S. Dept. of Health, Education & Welfare, 1965), by United States Food and Drug Administration (page images at HathiTrust)
- Project label : alphabetical listings by drug labeler. (Dept. of Justice, Drug Enforcement Administration, Office of Compliance and Regulatory Affairs, Regulatory Support Division, Information Systems Section : for sale by the Supt. of Docs., U.S. Govt. Print. Off., 1978), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs. Information Systems Section (page images at HathiTrust)
- Review of the research literature on the effects of health warning labels : a report to the United States Congress (Assistant Secretary for Health, Dept. of Health and Human Services, 1987), by Phillip Richardson, National Institute on Alcohol Abuse and Alcoholism (U.S.), and Macro Systems (page images at HathiTrust)
- Project label. Alphabetical listings by controlled generic drug ingredients. (Washington, D.C. : Department of Justice, Drug Enforcement Administration, Office of Compliance and Regulatory Affairs, Regulatory Support Division, Information Systems Section, 19-, in the 20th century), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs. Information Systems Section (page images at HathiTrust)
Filed under: Drugs -- Labeling -- United States -- BibliographyFiled under: Drugs -- Labeling -- United States -- PeriodicalsFiled under: Drugs -- Labeling -- Law and legislation -- United States- Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- Drug legislation hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983. (U.S. G.P.O., 1983), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- Drug labeling in developing countries. (U.S. Congress, Office of Technology Assessment, 1993), by United States Congress Office of Technology Assessment (page images at HathiTrust)
- Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394). (U.S. G.P.O., 2002), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
- Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983. (U.S. G.P.O., 1983), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- Prescription drug labeling and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills ... . (U.S. Govt. Print. Off., 1977), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance (page images at HathiTrust)
Filed under: Drugs, Nonprescription -- United States- Advertising for over-the-counter drugs : staff report and recommendations : public record no. 215-51, 16 CFR part 450 (The Commission ;, 1979), by United States Federal Trade Commission and Thomas J. Donegan (page images at HathiTrust)
- Summary of the report of the Advisory Review Panel on OTC Internal Analgesic, Antipyretic, and Antirheumatic Products. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Office of Public affairs, 1977), by Antipyretic United States. Food and Drug Administration. Advisory Review Panel on OTC Internal Analgesic (page images at HathiTrust)
- Compliance program reference : OTC drug monograph implementation (compliance program #7361.003). ([Center for Drugs and Biologics, 1985), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
- Look alike drugs hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, first session, on look alike drugs, October 14, 1981. (U.S. G.P.O., 1983), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime (page images at HathiTrust)
- Safety and efficacy of over-the-counter drug use by the elderly hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, first session, July 21, 1983. (G.P.O., 1984), by United States. Congress. House. Select Committee on Aging. Subcommittee on Health and Long-Term Care (page images at HathiTrust)
- Regulation of over-the-counter drugs hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979. (U.S. Govt. Print. Off., 1979), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
- Value of a pharmacist-controlled class has yet to be demonstrated: report (The Office ;, 1995), by United States General Accounting Office and United States. Congress. House. Committee on Commerce (page images at HathiTrust)
- Cold medications : health care or hype? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, April 8, 1992. (U.S. G.P.O. :, 1993), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
- A Doctor's advice on self-care (The Administration, 1990), by Frank E. Young, United States Food and Drug Administration, and Proprietary Association (page images at HathiTrust)
- Safe and sure self-care with over-the-counter medicines. ([Dept. of Health and Human Services, Food and Drug Administration, 1992), by United States Food and Drug Administration (page images at HathiTrust)
- Selecting your own medicine. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1980), by United States. Food and Drug Administration. Office of Public Affairs (page images at HathiTrust)
- [FDA's "exclusivity policy" concerning the labeling claims or "indications for use" of drug products for over-the-counter (OTC) use]. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1985), by United States Food and Drug Administration (page images at HathiTrust)
- Los Medicamentos sin receta médica : algunas precauciones para su uso. (Dept. of Health and Human Services, Food and Drug Administration, 1992), by United States Food and Drug Administration (page images at HathiTrust)
- Look alike drugs : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, first session, on look alike drugs, October 14, 1981. (U.S. G.P.O., 1983), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime (page images at HathiTrust)
- Safety and efficacy of over-the-counter drug use by the elderly : hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, first session, July 21, 1983. (G.P.O., 1984), by United States. Congress. House. Select Committee on Aging. Subcommittee on Health and Long-Term Care (page images at HathiTrust)
- Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001. (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
- The great American fraud. Articles on the nostrum evil and quackery reprinted from Collier's. (American Medical Association, 1912), by Samuel Hopkins Adams (page images at HathiTrust)
- Drugs most frequently used in office-based practice : national ambulatory medical care survey, 1980 (U.S. Dept. of Health and Human Services, Public Health Service, Office of Health Research, Statistics, and Technology, 1982), by Hugo K. Koch, National Center for Health Statistics (U.S.). Division of Health Care Statistics, and Statistics United States. Public Health Service. Office of Health Research (page images at HathiTrust)
- Drug utilization in general and family practice by characteristics of physicians and office visits : national ambulatory medical care survey, 1980 (U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Statistics, 1983), by Beulah K. Cypress and National Center for Health Statistics (U.S.) (page images at HathiTrust)
- Drugs most frequently used in office practice : national ambulatory medical care survey, 1981 (U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Statistics, 1983), by Hugo K. Koch and National Center for Health Statistics (U.S.) (page images at HathiTrust)
Filed under: Drugs, Nonprescription -- United States -- Costs- Department of Veterans Affairs pharmacy program with emphasis on OTC drugs, medical supplies, and dietary supplements : hearing before the Subcommittee on Hospitals and Health Care of the Committee on Veterans' Affairs, House of Representatives, One Hundred Fourth Congress, second session, June 11, 1996. (U.S. G.P.O. :, 1996), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Hospitals and Health Care (page images at HathiTrust)
- Opportunities to significantly reduce outpatient pharmacy costs (The Office ;, 1996), by United States General Accounting Office and United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Hospitals and Health Care (page images at HathiTrust)
Filed under: Drugs, Nonprescription -- Government policy -- United StatesFiled under: Drugs, Nonprescription -- Law and legislation -- United States- Advertising for over-the-counter drugs : public record 215-51, 16 CFR part 450 : report of the presiding officer on proposed trade regulation rule (Federal Trade Commission : for sale by the Supt. of Docs., U.S. Govt. Print. Off., 1978), by Roger J. Fitzpatrick and United States Federal Trade Commission (page images at HathiTrust)
- Preamble compilation : over-the-counter drugs, March 1936-March 1978 (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration : For sale by the Supt. of Docs., U.S. G.P.O., 1980), by United States Food and Drug Administration (page images at HathiTrust)
- Dietary Supplement and Nonprescription Drug Consumer Protection Act : report (to accompany S. 3546). (U.S. G.P.O. :, 2006), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
- Dextromethorphan Distribution Act of 2009 : report (to accompany H.R. 1259) (including cost estimate of the Congressional Budget Office). (U.S. G.P.O., 2009), by United States House. Committee on Energy and Commerce (page images at HathiTrust)
- Imitation Controlled Substances Act of 1983 : hearing before the Subcommittee on Alcoholism and Drug Abuse of the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congresses, first session, on S. 503 ... July 14, 1983. (U.S. G.P.O. :, 1983), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Alcoholism and Drug Abuse (page images at HathiTrust)
- An Act to Facilitate the Creation of Methamphetamine Precursor Electronic Logbook Systems, and for Other Purposes. (U.S. G.P.O. :, 2008), by United States (page images at HathiTrust)
More items available under broader and related terms at left. |